Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05099_nanopub.RAGwJtwi8z5n79wmTI95UwQwuyzjCYagqXxxWWFIRrAvY#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- drugbank:DB05099 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05099 label "Ancrod [drugbank:DB05099]" assertion.
- drugbank:DB05099 seeAlso DB05099 assertion.
- drugbank:DB05099 description "Ancrod (current brand name: Viprinex) is a defibrinogenating agent derived from the venom of the Malayan pit viper. The defribrinogenation of blood results in an anticoagulant effect. Currently, Viprinex®/ancrod is not approved or marketed in any country, but is being investigated as a stroke treatment in worldwide clinical trials. In January 2005, the U.S. FDA granted a 'fast-track status' for investigation of ancrod use in patients suffering from acute ischemic stroke, a life threatening condition caused by the blockage of blood vessels supplying blood and oxygen to portions of the brain, for which phase III trials are currently being conducted." assertion.
- drugbank:DB05099 identifier "drugbank:DB05099" assertion.
- drugbank:DB05099 title "Ancrod" assertion.
- drugbank:DB05099 drugbank_vocabulary:x-cas cas:9046-56-4 assertion.
- drugbank:DB05099 drugbank_vocabulary:drugbank-id "DB05099" assertion.
- drugbank:DB05099 bio2rdf_vocabulary:x-identifiers.org DB05099 assertion.
- drugbank:DB05099 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05099" assertion.
- drugbank:DB05099 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05099 bio2rdf_vocabulary:identifier "DB05099" assertion.
- drugbank:DB05099 drugbank_vocabulary:x-wikipedia wikipedia:Ancrod assertion.
- drugbank:DB05099 drugbank_vocabulary:x-dpd dpd:657271 assertion.